Mounjaro

Indiana-based pharmaceutical company Eli Lilly is facing product liability lawsuits in relation to their diabetes drug, Mounjaro. The medication, along with similar drugs Ozempic and Wegovy, has gained popularity for weight loss and management in obese patients. However, new evidence suggests that higher doses of Mounjaro used for weight loss can lead to serious health problems involving the gallbladder and gastrointestinal system. Users of Mounjaro have reported complications such as gallbladder disease, gallstones, gastroparesis (stomach paralysis), and other stomach conditions. It has been alleged that Eli Lilly was aware of these risks associated with Mounjaro … Read more